
    
      The purpose of this study is to demonstrate the superiority of paricalcitol treatment at
      early renal post-transplantation (M6) in the control of iPTH (Intact parathyroid hormone)
      compared to the use of vitamin D nutritional supplements (calcifediol) in patients with renal
      transplantation.
    
  